Why Patients Change from Wegovy to Mounjaro
Understanding Your Options to Change from Wegovy to Mounjaro
When you're ready to change from Wegovy to Mounjaro, understanding the key differences helps inform your decision. Mounjaro (tirzepatide) is a dual-action medication that targets both GIP and GLP-1 receptors, whilst Wegovy (semaglutide) works solely on GLP-1 receptors. This dual mechanism may offer different benefits for some patients, though both are prescription-only medicines requiring clinical assessment. The decision to change from Wegovy to Mounjaro should always involve your prescribing clinician who can evaluate your individual circumstances.
Cost considerations often influence the choice to change from Wegovy to Mounjaro, particularly given the different pricing structures and bundle options available. EverydayMeds provides both medications through the same streamlined service, ensuring continuity of care during your transition. Your medical history, current response to treatment, and personal preferences all factor into determining whether switching medications aligns with your weight management goals alongside a reduced-calorie diet and increased physical activity.
Mounjaro Pricing Comparison for Your Switch
Understanding the financial implications when you change from Wegovy to Mounjaro helps you make an informed decision. Mounjaro 2.5mg starts at £79.99 for new customers using code FIRST40 at checkout, with returning customers applying code DOSE25. Our 5mg dose costs £94.99, whilst the 7.5mg strength is priced at £99.99, and maintenance doses of 10mg and 15mg cost £139.99 and £209.99 respectively. These competitive prices make the transition financially advantageous for many patients considering the change from Wegovy to Mounjaro.
Bundle options provide additional value when you change from Wegovy to Mounjaro, with our Intro Duo (2.5mg & 5mg) at £169.99 and Progress Duo (5mg & 7.5mg) at £189.99. For patients requiring higher doses, the Advance Duo (7.5mg & 10mg) costs £269.99, whilst the Elevate Duo (10mg & 15mg) is £369.99. These packages ensure treatment continuity during your dose escalation phase, eliminating the need for multiple orders as you establish your optimal maintenance dose.
Clinical Evidence Supporting Your Change from Wegovy to Mounjaro
When evaluating whether to change from Wegovy to Mounjaro, clinical trial data provides valuable context. The SURMOUNT trials demonstrated that patients taking Mounjaro alongside diet and exercise may experience significant weight management benefits. SURMOUNT-1 showed average weight reductions of up to 22.5% at the highest dose over 72 weeks, though individual results vary considerably based on adherence, lifestyle factors, and genetic predisposition.
The dual mechanism action that patients access when they change from Wegovy to Mounjaro targets both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors simultaneously. This may offer enhanced appetite suppression and metabolic benefits compared to GLP-1-only medications, though head-to-head comparisons between trials should be interpreted cautiously due to different study designs and patient populations. Your prescriber can discuss how this evidence applies to your specific circumstances.
How Mounjaro Works After Your Change from Wegovy
Understanding the mechanism of action helps explain why some patients benefit when they change from Wegovy to Mounjaro. Tirzepatide activates both GIP and GLP-1 receptors in the brain's appetite centres, potentially providing enhanced satiety signals compared to single-receptor medications. This dual activation may slow gastric emptying more effectively, helping you feel fuller for longer periods after smaller meals. The medication also influences glucose metabolism and may reduce food cravings, particularly for high-calorie foods. These effects work synergistically with dietary modifications and exercise to support sustainable weight management. The once-weekly injection schedule remains convenient, similar to your previous treatment regimen.
Your Ordering Process to Change from Wegovy to Mounjaro
Making the change from Wegovy to Mounjaro through EverydayMeds involves a straightforward three-step process designed for safety and convenience. Complete our 3-minute online clinical assessment detailing your current treatment history, reasons for switching, and any side effects experienced with your previous medication. Our UK-qualified prescribers review your information within 3 working days (or 24 hours with express service), ensuring the switch is clinically appropriate for your circumstances. Once approved, your Mounjaro ships via next-day delivery in temperature-controlled packaging, maintaining the cold-chain integrity essential for this prescription-only medicine. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout your treatment transition.
Storage and Practical Considerations for Your Mounjaro Switch
When you change from Wegovy to Mounjaro, storage requirements differ slightly from your previous medication. Mounjaro must be refrigerated at 2-8°C before first use and can remain at room temperature (below 30°C) for up to 21 days once removed from the fridge. The KwikPen delivery system provides consistent dosing through a user-friendly injection mechanism similar to other pen devices. Dose escalation follows a structured schedule: 2.5mg for weeks 1-4, 5mg for weeks 5-8, then increasing every 4 weeks until reaching your maintenance dose. Most patients achieve optimal results at 10mg or 15mg weekly, though your prescriber will determine the appropriate target dose based on your response and tolerability. Injection sites should be rotated between thigh, abdomen, or upper arm to minimize local reactions.
Switching Protocols When You Change from Wegovy to Mounjaro
The transition process when you change from Wegovy to Mounjaro requires careful timing and medical supervision to ensure optimal outcomes. Your prescriber will typically recommend completing your current Wegovy pen before starting Mounjaro, allowing a brief washout period to minimize potential interactions. Some clinicians prefer overlapping the medications for one dose to maintain therapeutic continuity, whilst others recommend a clean transition depending on your current dose and treatment response.
Dose conversion isn't directly equivalent when you change from Wegovy to Mounjaro due to different mechanisms of action and potency profiles. Patients switching from Wegovy 2.4mg maintenance typically start Mounjaro at the standard 2.5mg initiation dose and follow the full escalation schedule. This approach allows your body to adapt to the dual-receptor mechanism whilst minimizing gastrointestinal side effects commonly experienced during treatment transitions. Your EverydayMeds prescriber will provide specific timing instructions based on your individual treatment history.
Completing Your Change from Wegovy to Mounjaro with EverydayMeds
Ready to make the change from Wegovy to Mounjaro? Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment today. New customers save with code FIRST40, whilst returning patients use DOSE25 at checkout for immediate savings. Our expert clinical team provides ongoing support throughout your treatment transition, ensuring you achieve optimal results with your new medication regimen. Both medications remain available through our service, providing flexibility should you need to adjust your treatment approach. Take the first step towards your weight management goals with confidence, backed by our comprehensive clinical support and competitive pricing.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
